Willem J. Lammers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Willem J. Lammers has a total of 364 co-authors. Here are the top co-authors by number of shared publications:
- Andrew L. Mason
Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
10 shared publications Annarosa Floreani
Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy
9 shared publicationsHenk R. van Buuren
Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands
9 shared publications- Albert Parés
Liver Unit, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain
8 shared publications Christophe Corpechot
Centre de Référence des Maladies Inflammatoires des Voies Biliaires, Hoôpital Saint-Antoine, Paris, France
8 shared publicationsBettina E. Hansen
Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands; Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
7 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Elsevier in Pancreatology
Treatment of chronic pancreatitis with pancreatic duct obstruction in clinical practice: An international expert survey and case vignette study
- 16 November 2026
- Published by Elsevier in Pancreatology
Open AccessTreatment of chronic pancreatitis with pancreatic duct obstruction in clinical practice: An international expert survey and case vignette study
- Open Access
- 24 August 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 83 (5) , 921-922
Recurrent acute pancreatitis caused by a duodenal diverticulum: The diagnostic value of secretin‐enhanced magnetic resonance cholangiopancreatography
- 24 August 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 83 (5) , 921-922
Open AccessRecurrent acute pancreatitis caused by a duodenal diverticulum: The diagnostic value of secretin‐enhanced magnetic resonance cholangiopancreatography
- Open Access
- 13 August 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (7) , e70275
EUS‐Guided Gallbladder Drainage for Acute Cholecystitis in the Western World: Heterogeneity in Current Practice and the Relation With Patient Outcome
Background: Laparoscopic cholecystectomy is the standard treatment for acute cholecystitis (AC), but some patients are unfit for (immediate) surgery. Endoscopic ultrasound‐guided gallbladder drainage (EUS‐GBD) using a lumen‐apposing metal stent (LAMS) is increasingly used in this population. Objective: This multicenter cohort study aimed to evaluate practice patterns in EUS‐GBD across Western centers and to identify factors that influence outcomes. Design: We retrospectively analyzed data from patients undergoing EUS‐GBD for AC across 18 centers. Patient‐related, procedural and outcome data were collected. The primary outcomes of interest were LAMS‐related adverse events (AEs), recurrent biliary disease, recurrent acute cholecystitis, and all‐cause mortality. Time‐to‐event analyses were performed using center‐stratified Cox proportional hazards and Fine–Gray competing‐risk models to identify LAMS procedural factors associated with clinical outcomes. Results: We included 496 patients with a median follow‐up of 176 days (IQR 44–569). Technical and clinical success rates of EUS‐GBD were 98.2% and 93.5%, respectively. LAMS‐related AEs and recurrent biliary disease occurred in 11.1% and 18.8% of patients, respectively. Transduodenal access was associated with a lower cumulative incidence of LAMS‐related AEs compared with transgastric access (SHR 0.42, 95% CI 0.23–0.76, p = 0.004) and lower rates of recurrent biliary disease and recurrent acute cholecystitis during follow‐up. Larger LAMS diameters (> 10 mm) were associated with a lower risk of recurrent acute cholecystitis and all‐cause mortality. No association between coaxial DPPS placement and improved long‐term outcomes could be demonstrated after competing‐risk adjustment. Among patients undergoing interval cholecystectomy ( N = 46), LAMS‐related conversion from laparoscopy to laparotomy occurred in 3 cases (6.5%). Conclusions: In this large cohort study, transduodenal access route and choice of a large (> 10 mm) LAMS diameter were associated with improved outcomes of EUS‐GBD. EUS‐GBD may be a feasible option as a bridge to laparoscopic cholecystectomy, with limited risk of conversion to laparotomy. The findings of our study require prospective validation.
- 13 August 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (7) , e70275
Open AccessEUS‐Guided Gallbladder Drainage for Acute Cholecystitis in the Western World: Heterogeneity in Current Practice and the Relation With Patient Outcome
Background: Laparoscopic cholecystectomy is the standard treatment for acute cholecystitis (AC), but some patients are unfit for (immediate) surgery. Endoscopic ultrasound‐guided gallbladder drainage (EUS‐GBD) using a lumen‐apposing metal stent (LAMS) is increasingly used in this population. Objective: This multicenter cohort study aimed to evaluate practice patterns in EUS‐GBD across Western centers and to identify factors that influence outcomes. Design: We retrospectively analyzed data from patients undergoing EUS‐GBD for AC across 18 centers. Patient‐related, procedural and outcome data were collected. The primary outcomes of interest were LAMS‐related adverse events (AEs), recurrent biliary disease, recurrent acute cholecystitis, and all‐cause mortality. Time‐to‐event analyses were performed using center‐stratified Cox proportional hazards and Fine–Gray competing‐risk models to identify LAMS procedural factors associated with clinical outcomes. Results: We included 496 patients with a median follow‐up of 176 days (IQR 44–569). Technical and clinical success rates of EUS‐GBD were 98.2% and 93.5%, respectively. LAMS‐related AEs and recurrent biliary disease occurred in 11.1% and 18.8% of patients, respectively. Transduodenal access was associated with a lower cumulative incidence of LAMS‐related AEs compared with transgastric access (SHR 0.42, 95% CI 0.23–0.76, p = 0.004) and lower rates of recurrent biliary disease and recurrent acute cholecystitis during follow‐up. Larger LAMS diameters (> 10 mm) were associated with a lower risk of recurrent acute cholecystitis and all‐cause mortality. No association between coaxial DPPS placement and improved long‐term outcomes could be demonstrated after competing‐risk adjustment. Among patients undergoing interval cholecystectomy ( N = 46), LAMS‐related conversion from laparoscopy to laparotomy occurred in 3 cases (6.5%). Conclusions: In this large cohort study, transduodenal access route and choice of a large (> 10 mm) LAMS diameter were associated with improved outcomes of EUS‐GBD. EUS‐GBD may be a feasible option as a bridge to laparoscopic cholecystectomy, with limited risk of conversion to laparotomy. The findings of our study require prospective validation.
- Open Access
- 5 June 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (5) , e70220
Endoscopic Ultrasonography‐Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health‐Economic Evaluation Alongside a Randomized Trial
Background: There is a paucity of data on the cost‐utility of endoscopic ultrasonography‐guided gastroenterostomy (EUS‐GE) compared with surgical gastrojejunostomy (SGJ) as palliative treatment of malignant gastric outlet obstruction. Methods: In the ENDURO trial, 98 patients with malignant gastric outlet obstruction from 12 Dutch hospitals were randomized between EUS‐GE ( N = 48) and SGJ ( N = 50). Cost utility was evaluated from a healthcare perspective with a time horizon of 1 month. A bottom‐up approach was used to calculate the costs of each intervention, including the per‐minute price of the endoscopy and operating room (OR), considering personnel, construction, inventory and overhead costs. Other in‐hospital costs were calculated using insurance claim data. Effectiveness was displayed as quality‐adjusted life years (QALY). Bootstrapping was performed to estimate uncertainty. Results: The calculated per‐minute price for the endoscopy room was €8.64 (US $9.34). The per‐minute price for an OR was €11.78 (US $12.74). The mean intervention costs were estimated at €4405.40 (US $4762.68) for EUS‐GE and €3393.71 (US $3668.93) for SGJ. Mean total in‐hospital costs were lower following EUS‐GE (€5172 [US $5591]) than after SGJ (€10,458 [US $11,306]), mainly due to a shorter length of hospital stay following EUS‐GE. Bootstrapping showed that 99.9% of iterations resulted in lower costs for EUS‐GE. Mean difference in 1‐month QALY contribution was 0.004 in favor of EUS‐GE. Most iterations fall within the bottom right quadrant (95.6%) of the cost‐effectiveness plane, indicating lower costs and improved QALY contribution for EUS‐GE. Discussion: In this study, EUS‐GE was more cost effective than SGJ. The additional intervention costs were clearly outweighed by a decrease in in‐hospital costs after the procedure.
- 5 June 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (5) , e70220
Open AccessEndoscopic Ultrasonography‐Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health‐Economic Evaluation Alongside a Randomized Trial
Background: There is a paucity of data on the cost‐utility of endoscopic ultrasonography‐guided gastroenterostomy (EUS‐GE) compared with surgical gastrojejunostomy (SGJ) as palliative treatment of malignant gastric outlet obstruction. Methods: In the ENDURO trial, 98 patients with malignant gastric outlet obstruction from 12 Dutch hospitals were randomized between EUS‐GE ( N = 48) and SGJ ( N = 50). Cost utility was evaluated from a healthcare perspective with a time horizon of 1 month. A bottom‐up approach was used to calculate the costs of each intervention, including the per‐minute price of the endoscopy and operating room (OR), considering personnel, construction, inventory and overhead costs. Other in‐hospital costs were calculated using insurance claim data. Effectiveness was displayed as quality‐adjusted life years (QALY). Bootstrapping was performed to estimate uncertainty. Results: The calculated per‐minute price for the endoscopy room was €8.64 (US $9.34). The per‐minute price for an OR was €11.78 (US $12.74). The mean intervention costs were estimated at €4405.40 (US $4762.68) for EUS‐GE and €3393.71 (US $3668.93) for SGJ. Mean total in‐hospital costs were lower following EUS‐GE (€5172 [US $5591]) than after SGJ (€10,458 [US $11,306]), mainly due to a shorter length of hospital stay following EUS‐GE. Bootstrapping showed that 99.9% of iterations resulted in lower costs for EUS‐GE. Mean difference in 1‐month QALY contribution was 0.004 in favor of EUS‐GE. Most iterations fall within the bottom right quadrant (95.6%) of the cost‐effectiveness plane, indicating lower costs and improved QALY contribution for EUS‐GE. Discussion: In this study, EUS‐GE was more cost effective than SGJ. The additional intervention costs were clearly outweighed by a decrease in in‐hospital costs after the procedure.
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Cholangioscopy in the Diagnostic and Therapeutic Work-Up of Intraductal Papillary Neoplasms of the Bile Duct: A Systematic Review and Meta-Analysis
Background Intraductal papillary neoplasms of the bile duct (IPNB) are rare and diagnostically challenging, particularly in assessing invasiveness and intraductal spread. Cholangioscopy offers promise through direct visualization and targeted biopsies. The aim of this study was to review the current literature on the role of cholangioscopy in diagnosing IPNB, assessment of disease extent, and therapeutic applications. Methods The EMBASE, Medline Ovid, Web of Science, Cochrane CENTRAL, and Google Scholar databases were systematically searched for articles. Eligible articles investigated cohorts of patients who underwent cholangioscopy for (suspected) IPNB. Results In all, 17 studies comprising 224 patients were included. Despite substantial heterogeneity, cholangioscopy demonstrated high technical success and visualization rates, with a low adverse event rate. Several cholangioscopy-based classification systems describing mucosal and microvascular patterns of IPNB have been proposed, but none are widely adopted. The impact on clinical decision-making was primarily related to confirming tumour invasiveness and assessing preoperative intraductal extent. Two studies showed that cholangioscopy is feasible for therapeutic purposes in IPNB, such as polypectomy and electrocoagulation. Conclusion Cholangioscopy is increasingly important in the diagnosis and management of IPNB, but standardized visual criteria and consistent biopsy accuracy remain lacking. Therapeutic applications are uncommon yet appear feasible in selected cases. Given the rarity of IPNB, collaborative registries and pooled observational data are needed to support standardized clinical protocols.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Open AccessCholangioscopy in the Diagnostic and Therapeutic Work-Up of Intraductal Papillary Neoplasms of the Bile Duct: A Systematic Review and Meta-Analysis
Background Intraductal papillary neoplasms of the bile duct (IPNB) are rare and diagnostically challenging, particularly in assessing invasiveness and intraductal spread. Cholangioscopy offers promise through direct visualization and targeted biopsies. The aim of this study was to review the current literature on the role of cholangioscopy in diagnosing IPNB, assessment of disease extent, and therapeutic applications. Methods The EMBASE, Medline Ovid, Web of Science, Cochrane CENTRAL, and Google Scholar databases were systematically searched for articles. Eligible articles investigated cohorts of patients who underwent cholangioscopy for (suspected) IPNB. Results In all, 17 studies comprising 224 patients were included. Despite substantial heterogeneity, cholangioscopy demonstrated high technical success and visualization rates, with a low adverse event rate. Several cholangioscopy-based classification systems describing mucosal and microvascular patterns of IPNB have been proposed, but none are widely adopted. The impact on clinical decision-making was primarily related to confirming tumour invasiveness and assessing preoperative intraductal extent. Two studies showed that cholangioscopy is feasible for therapeutic purposes in IPNB, such as polypectomy and electrocoagulation. Conclusion Cholangioscopy is increasingly important in the diagnosis and management of IPNB, but standardized visual criteria and consistent biopsy accuracy remain lacking. Therapeutic applications are uncommon yet appear feasible in selected cases. Given the rarity of IPNB, collaborative registries and pooled observational data are needed to support standardized clinical protocols.
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Initial Results from a Novel Video Cholangiopancreatoscope: An International Multicenter Study
Background Novel 8.9-Fr and 11-Fr digital cholangiopancreatoscopes (Scivita Medical) have recently become available in Europe, but data on technical performance and safety remain limited. We report initial real-world experience with the Scivita platform. Methods This international, multicenter, retrospective cohort study included consecutive patients undergoing digital single-operator cholangioscopy (dSOC) or pancreatoscopy (dSOP) between March and October 2025 at 10 European centers. The primary outcome was technical success, defined as achievement of the intended procedural goal. Secondary outcomes included intra- and post-procedural complications, classified using the AGREE classification. Results In total, 77 patients (54.5% female; median age 70 years [IQR: 60–76]) were included. In 68 patients, 78 dSOC procedures achieved an overall technical success rate of 91% (71/78): choledocholithiasis 87% (33/38), biliary strictures 96% (24/25), selective cannulation 100% (2/2), evaluation of intraductal margins 50% (1/2), and migrated stent removal 100% (1/1). In all, 9 patients underwent 11 dSOP procedures, with an overall technical success rate of 63.6% (7/11): stone clearance 66.7% (4/6), intraductal papillary mucinous neoplasm assessment 50% (1/2), bridging pancreatic duct disruption 0% (0/1). No intraprocedural complications occurred. Postprocedural complications followed six dSOC procedures: cholangitis in two, mild post-ERCP pancreatitis in two, and abdominal pain without a clear substrate in two. One patient developed mild pancreatitis after dSOP. Conclusion Scivita dSOC demonstrated high technical success and an excellent safety profile. Larger prospective studies are warranted to validate these findings and define the role of dSOC and dSOP of Scivita cholangiopancreatoscopy in clinical practice, while also taking into account cost-effectiveness and environmental impact.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Open AccessInitial Results from a Novel Video Cholangiopancreatoscope: An International Multicenter Study
Background Novel 8.9-Fr and 11-Fr digital cholangiopancreatoscopes (Scivita Medical) have recently become available in Europe, but data on technical performance and safety remain limited. We report initial real-world experience with the Scivita platform. Methods This international, multicenter, retrospective cohort study included consecutive patients undergoing digital single-operator cholangioscopy (dSOC) or pancreatoscopy (dSOP) between March and October 2025 at 10 European centers. The primary outcome was technical success, defined as achievement of the intended procedural goal. Secondary outcomes included intra- and post-procedural complications, classified using the AGREE classification. Results In total, 77 patients (54.5% female; median age 70 years [IQR: 60–76]) were included. In 68 patients, 78 dSOC procedures achieved an overall technical success rate of 91% (71/78): choledocholithiasis 87% (33/38), biliary strictures 96% (24/25), selective cannulation 100% (2/2), evaluation of intraductal margins 50% (1/2), and migrated stent removal 100% (1/1). In all, 9 patients underwent 11 dSOP procedures, with an overall technical success rate of 63.6% (7/11): stone clearance 66.7% (4/6), intraductal papillary mucinous neoplasm assessment 50% (1/2), bridging pancreatic duct disruption 0% (0/1). No intraprocedural complications occurred. Postprocedural complications followed six dSOC procedures: cholangitis in two, mild post-ERCP pancreatitis in two, and abdominal pain without a clear substrate in two. One patient developed mild pancreatitis after dSOP. Conclusion Scivita dSOC demonstrated high technical success and an excellent safety profile. Larger prospective studies are warranted to validate these findings and define the role of dSOC and dSOP of Scivita cholangiopancreatoscopy in clinical practice, while also taking into account cost-effectiveness and environmental impact.
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP) , a28849422
Bridging the Gap between Literature and Practice: Nationwide Outcomes of Endoscopic Ultrasound-guided Hepatico-gastrostomy
Background Endoscopic ultrasound-guided hepatico-gastrostomy (EUS-HGS) enables internal biliary drainage via the stomach in patients with altered anatomy, inadequate left hepatic duct drainage, or duodenal obstruction. The technically demanding procedure is only performed at expert centers in the Netherlands. Most available evidence originates from selected cohorts, overestimating real-world outcomes. We evaluated outcomes of EUS-HGS in a nationwide cohort. Methods This nationwide retrospective cohort study included all patients in the Netherlands who underwent EUS-HGS attempts between 2009 and 2025, outside of prospective studies. The primary outcome was technical success. Secondary outcomes included clinical success, complications, time to recurrent biliary obstruction (RBO), and overall survival. Results A total of 107 procedures in 105 patients were analyzed (median age: 68 years [IQR: 59–76]; 55%: male). Technical success was achieved in 77% (81/105). Failures were due to absence of a safe puncture tract (n = 7), unsuccessful bile duct puncture (n = 3), inability to achieve deep guidewire insertion (n = 3), failed fistula formation (n = 3), or unsuccessful or nonattempted stent placement (n = 7). Clinical success occurred in 78% of technically successful cases (63/81), corresponding to 60% in intention-to-treat analysis (63/105). Procedural complications occurred in 16/107 (15%), and postprocedural complications in 17/107 (16%). One procedure-related death occurred. RBO occurred in 28% (23/81) during a median follow-up of 61 days [IQR: 23–131]. Median overall survival was 91 days [IQR: 66–155]. Conclusion In this nationwide real-world cohort, technical and clinical success rates of EUS-HGS were modest compared with selected expert series, underscoring the need for prospective studies to improve patient selection, stent strategies, and procedural safety.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP) , a28849422
Open AccessBridging the Gap between Literature and Practice: Nationwide Outcomes of Endoscopic Ultrasound-guided Hepatico-gastrostomy
Background Endoscopic ultrasound-guided hepatico-gastrostomy (EUS-HGS) enables internal biliary drainage via the stomach in patients with altered anatomy, inadequate left hepatic duct drainage, or duodenal obstruction. The technically demanding procedure is only performed at expert centers in the Netherlands. Most available evidence originates from selected cohorts, overestimating real-world outcomes. We evaluated outcomes of EUS-HGS in a nationwide cohort. Methods This nationwide retrospective cohort study included all patients in the Netherlands who underwent EUS-HGS attempts between 2009 and 2025, outside of prospective studies. The primary outcome was technical success. Secondary outcomes included clinical success, complications, time to recurrent biliary obstruction (RBO), and overall survival. Results A total of 107 procedures in 105 patients were analyzed (median age: 68 years [IQR: 59–76]; 55%: male). Technical success was achieved in 77% (81/105). Failures were due to absence of a safe puncture tract (n = 7), unsuccessful bile duct puncture (n = 3), inability to achieve deep guidewire insertion (n = 3), failed fistula formation (n = 3), or unsuccessful or nonattempted stent placement (n = 7). Clinical success occurred in 78% of technically successful cases (63/81), corresponding to 60% in intention-to-treat analysis (63/105). Procedural complications occurred in 16/107 (15%), and postprocedural complications in 17/107 (16%). One procedure-related death occurred. RBO occurred in 28% (23/81) during a median follow-up of 61 days [IQR: 23–131]. Median overall survival was 91 days [IQR: 66–155]. Conclusion In this nationwide real-world cohort, technical and clinical success rates of EUS-HGS were modest compared with selected expert series, underscoring the need for prospective studies to improve patient selection, stent strategies, and procedural safety.
- Open Access
- 8 January 2026
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 61 (2) , 231-240
The impact of biliary drainage on chemotherapy initiation and survival in patients with non-resected perihilar cholangiocarcinoma: a population-based study in the Netherlands
Perihilar cholangiocarcinoma (pCCA) is a rare malignancy originating from the bile duct bifurcation which is often diagnosed in an advanced stage. At presentation, most patients present with jaundice requiring biliary drainage. Palliative chemotherapy (pCTx) has a positive impact on survival and quality of life. The primary aim of this study was to investigate the impact of biliary drainage on pCTx initiation in patients with non-resected pCCA. Individual patient data from all Dutch patients diagnosed with non-resected pCCA between 2015 and 2020 were retrieved from the Netherlands Cancer Registry. Primary outcome were factors associated with initiation of pCTx, analysed by multivariable competing risk regression analysis. A total of 1265 patients were included, of whom 242 patients (19.1%) received pCTx after a median interval of 72 days [IQR 43-110 days] after initial presentation. Patients who underwent biliary drainage did not receive pCTx more often. If performed, drainage at a referral hospital (HR:0.65, 95%CI: 0.42-0.99), ≥3 drainage procedures performed (HR:0.53, 95%CI: 0.32-0.88), and drainage performed ≥14 days after presentation (HR:0.70, 95%CI: 0.49-0.99) were associated with no pCTx. Median overall survival for those who received pCTx and those who did not was 12.8 months [95%CI: 11.7-14.2] and 2.7 months [95%CI: 2.4-3.1]. The need for biliary drainage did not affect the initiation of pCTx. When indicated, biliary drainage should be performed as quick as possible in an academic center to improve the rate of patients receiving pCTx.
- 8 January 2026
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 61 (2) , 231-240
Open AccessThe impact of biliary drainage on chemotherapy initiation and survival in patients with non-resected perihilar cholangiocarcinoma: a population-based study in the Netherlands
Perihilar cholangiocarcinoma (pCCA) is a rare malignancy originating from the bile duct bifurcation which is often diagnosed in an advanced stage. At presentation, most patients present with jaundice requiring biliary drainage. Palliative chemotherapy (pCTx) has a positive impact on survival and quality of life. The primary aim of this study was to investigate the impact of biliary drainage on pCTx initiation in patients with non-resected pCCA. Individual patient data from all Dutch patients diagnosed with non-resected pCCA between 2015 and 2020 were retrieved from the Netherlands Cancer Registry. Primary outcome were factors associated with initiation of pCTx, analysed by multivariable competing risk regression analysis. A total of 1265 patients were included, of whom 242 patients (19.1%) received pCTx after a median interval of 72 days [IQR 43-110 days] after initial presentation. Patients who underwent biliary drainage did not receive pCTx more often. If performed, drainage at a referral hospital (HR:0.65, 95%CI: 0.42-0.99), ≥3 drainage procedures performed (HR:0.53, 95%CI: 0.32-0.88), and drainage performed ≥14 days after presentation (HR:0.70, 95%CI: 0.49-0.99) were associated with no pCTx. Median overall survival for those who received pCTx and those who did not was 12.8 months [95%CI: 11.7-14.2] and 2.7 months [95%CI: 2.4-3.1]. The need for biliary drainage did not affect the initiation of pCTx. When indicated, biliary drainage should be performed as quick as possible in an academic center to improve the rate of patients receiving pCTx.
- Open Access
- 7 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 13 (CP) , a25775449
Interobserver variability in lymph node evaluation with endoscopic ultrasonography in cholangiocarcinoma
Accurate preoperative lymph node (LN) assessment is crucial for patients with intrahepatic cholangiocarcinoma (iCCA) and perihilar cholangiocarcinoma (pCCA) because presence of LN metastases significantly reduces survival rates and can contraindicate surgical resection. Endoscopic ultrasound (EUS) provides a reliable method for LN assessment with the advantage of enabling tissue acquisition for pathological confirmation. This study aimed to assess interobserver agreement among endosonographers in evaluating LN characteristics in patients with iCCA and pCCA.A cross-sectional survey study was conducted among 24 endosonographers. Participants reviewed 42 EUS images from iCCA and pCCA patients, classifying LNs based on six characteristics (demarcation, shape, echogenicity, homogeneity, suspiciousness, and need to retrieve tissue). Interobserver agreement was determined using Light’s kappa statistics. Accuracy, sensitivity, and specificity in identifying malignant LNs were calculated.Overall kappa values indicated moderate to fair agreement on LN characteristics, with Kappa values of 0.24 for demarcation, 0.45 for shape, 0.38 for echogenicity, 0.52 for homogeneity, and 0.36 for suspiciousness. Overall accuracy of endosonographers in correctly identifying malignant LNs was 62%, with individual accuracy ranging from 44 to 75%. Sensitivity was 60% (range: 29%–90%) and specificity was 64% (range: 28%–89%).Endosonographic assessment of LN morphology and characterization demonstrates considerable variability among endosonographers. Thus, there is a clear need for standardization in preoperative LN evaluation, including establishing consensus about when to perform tissue acquisition, based on objective criteria such as short-axis diameter. Further research is required to refine and optimize these guidelines.
- 7 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 13 (CP) , a25775449
Open AccessInterobserver variability in lymph node evaluation with endoscopic ultrasonography in cholangiocarcinoma
Accurate preoperative lymph node (LN) assessment is crucial for patients with intrahepatic cholangiocarcinoma (iCCA) and perihilar cholangiocarcinoma (pCCA) because presence of LN metastases significantly reduces survival rates and can contraindicate surgical resection. Endoscopic ultrasound (EUS) provides a reliable method for LN assessment with the advantage of enabling tissue acquisition for pathological confirmation. This study aimed to assess interobserver agreement among endosonographers in evaluating LN characteristics in patients with iCCA and pCCA.A cross-sectional survey study was conducted among 24 endosonographers. Participants reviewed 42 EUS images from iCCA and pCCA patients, classifying LNs based on six characteristics (demarcation, shape, echogenicity, homogeneity, suspiciousness, and need to retrieve tissue). Interobserver agreement was determined using Light’s kappa statistics. Accuracy, sensitivity, and specificity in identifying malignant LNs were calculated.Overall kappa values indicated moderate to fair agreement on LN characteristics, with Kappa values of 0.24 for demarcation, 0.45 for shape, 0.38 for echogenicity, 0.52 for homogeneity, and 0.36 for suspiciousness. Overall accuracy of endosonographers in correctly identifying malignant LNs was 62%, with individual accuracy ranging from 44 to 75%. Sensitivity was 60% (range: 29%–90%) and specificity was 64% (range: 28%–89%).Endosonographic assessment of LN morphology and characterization demonstrates considerable variability among endosonographers. Thus, there is a clear need for standardization in preoperative LN evaluation, including establishing consensus about when to perform tissue acquisition, based on objective criteria such as short-axis diameter. Further research is required to refine and optimize these guidelines.
- Open Access
- 1 January 2025
- Published by S. Karger AG in Case Reports in Gastroenterology
- Vol. 19 (1) , 574-580
Delayed Jejunal Perforation after Endoscopic Ultrasound-Guided Gastroenterostomy: A Case Report and Literature Review
Introduction: Endoscopic ultrasound-guided gastroenterostomy is an emerging treatment for malignant gastric outlet obstruction, with high clinical and technical success rates and reported complication risks around 10%. However, the long-term risks associated with the presence of a metal stent remain unclear. Case Presentation: We present the case of a 35-year-old male with duodenal carcinoma and peritoneal metastases, treated with endoscopic ultrasound-guided gastroenterostomy because of gastric outlet obstruction, who developed a delayed jejunal perforation 10 months after the procedure. The perforation, likely related to the lumen-apposing metal stent, was resected. Thereafter, the patient recovered and resumed immunotherapy with no measurable disease on follow-up computed tomography. Conclusion: This report describes a case with a delayed jejunal perforation 10 months after endoscopic ultrasound-guided gastroenterostomy in a patient with metastatic duodenal carcinoma with complete treatment response to immunotherapy. We advise stent removal once the duodenal obstruction has resolved, given the potential risk of complications associated with prolonged stents in place.
- 1 January 2025
- Published by S. Karger AG in Case Reports in Gastroenterology
- Vol. 19 (1) , 574-580
Open AccessDelayed Jejunal Perforation after Endoscopic Ultrasound-Guided Gastroenterostomy: A Case Report and Literature Review
Introduction: Endoscopic ultrasound-guided gastroenterostomy is an emerging treatment for malignant gastric outlet obstruction, with high clinical and technical success rates and reported complication risks around 10%. However, the long-term risks associated with the presence of a metal stent remain unclear. Case Presentation: We present the case of a 35-year-old male with duodenal carcinoma and peritoneal metastases, treated with endoscopic ultrasound-guided gastroenterostomy because of gastric outlet obstruction, who developed a delayed jejunal perforation 10 months after the procedure. The perforation, likely related to the lumen-apposing metal stent, was resected. Thereafter, the patient recovered and resumed immunotherapy with no measurable disease on follow-up computed tomography. Conclusion: This report describes a case with a delayed jejunal perforation 10 months after endoscopic ultrasound-guided gastroenterostomy in a patient with metastatic duodenal carcinoma with complete treatment response to immunotherapy. We advise stent removal once the duodenal obstruction has resolved, given the potential risk of complications associated with prolonged stents in place.